Healthcare

SEP has been an active investor in the healthcare and medical technology sector for many years. We have extensive experience and a wide range of specialist skills within our team of healthcare investment professionals.  This includes commercial and research backgrounds in biotechnology, clinical trials and medical devices.

We are open to investing in early stage healthcare ventures, as well as more established companies that are looking to fund a step up in their sales and marketing. Our successes range from novel medical devices and therapies, to innovative software and services to the healthcare industry.

Our main areas of interest include medical devices, diagnostics, specialty pharmaceuticals, as well as platform and enabling technologies and new therapeutics. 

More generally, we are interested in healthcare companies that have strong business models or commercialisation potential, as well as those that cross over into other sectors and industries.

Related Companies

Cmed - Contract Research Organisation
Craneware (LSE:CRW) - Audit software for Healthcare billing
Heartscape - Next generation ECG
Stentys - Stents for blocked arteries
Daysoft - Daily disposable contact lenses
Voxar (Barco) - 3D medical imaging software
Gendel - Tumour therapies
Intercytex (LSE:ICX) - Hair and organ regenerative medicine
BioVex - Virus based cancer therapeutics
Cyclacel (NDAQ:CYCC) - Cancer therapeutics
Sosei (TSE:4565) - Speciality pharmaceuticals
Biovation (NYX: MRK) - Antibody and protein engineering

Investment Team

Interviews

Philip Astley-Sparke CEO, Biovex

Philip Astley-Sparke Image

Please download the latest flash player and make sure javascript is turned on to see the video content.

Ron Hamilton Image
Ron Hamilton
Chairman, daysoftLink to Ron Hamilton
Gonzague Issenmann Image
Gonzague Issenmann
CEO, StentysLink to Gonzague Issenmann
Nick Higgins Image
Nick Higgins
CEO, IntercytexLink to Nick Higgins